Good Morning,
Welcome to this week’s dive into the frontier of longevity technology, where human aspirations intertwine with cutting-edge tech to redefine our lifespan and quality of life.
Today we delve into Brian Johnson’s audacious journey, driven by an algorithm, as he invests millions in anti-aging strategies – some groundbreaking, some controversial. Meanwhile, OM1’s latest AI-enhanced dataset presents a transformative glimpse into the role of artificial intelligence in shaping the future of personalized medicine and combating chronic conditions. And, with Arctop pioneering the translation of brain signals to visible reality, including VR headsets, the possibilities seem endless. From personal quests to large-scale innovations, this edition captures the essence of our relentless pursuit for longevity.
The evolution is in progress…
Living Through an Algorithm (Rolling Stone)
Brian Johnson is now claiming his life is now directed by an algorithm rather than his own decisions, Johnson has spent around $2 million yearly for the past two years in pursuit of anti-aging strategies. His regimen includes taking over 100 supplements daily, adhering to a strict diet, and experimenting with various treatments – even ones as eyebrow-raising as blood-plasma donations from his son and penis rejuvenation via shockwave therapy.
While he’s open about his journey and even offers his protocol for free to help others, experts in the field have expressed doubts about the project’s viability. Despite the skepticism, Johnson’s radical approach has sparked significant public interest, raising questions about the intersection of technology and our quest for longevity. Is the algorithm the future of human existence? Only time will tell.
Brain Activity Converted to VR Headsets (Pulse 2.0)
Arctop, an innovative software designed to decode brain signals, has clinched $10 million in Series A funding, thanks to support from Fifth Growth Fund and Supermoon Capital. Co-founded in 2016 by neuroscientist Dan Furman and software expert Eitan Kay, Arctop translates brain activity captured by wearables, such as headbands and VR headsets, into real-time information that can be used in diverse applications—from personalized learning to emotion-responsive experiences.
Users’ privacy is said to remain uncompromised, as Arctop promises not to share raw brain data and offers an easy-to-use dashboard for data management. With a background in aiding Stephen Hawking communicate through brain-computer interfaces, Furman envisions the software’s game-changing applications, especially in the medical field, where partnerships like one with Stanford Medicine are already in motion.
Personalized Medicine is the Future of Access (Longevity Technology)
OM1, a trailblazing health tech company, recently launched a comprehensive Parkinson’s disease dataset, encompassing data from over 7,000 patients across the US. This AI-enhanced dataset not only offers insights into PD but also showcases the potential of technology in driving the future of longevity and personalized medicine.
Dr. Carl Marci of OM1 emphasizes that such real-world datasets can significantly expedite medical research, promising not just extended lifespan but improved quality of life. As the longevity sector evolves, the fusion of AI and multi-sourced data, like that from OM1, is set to redefine our understanding of chronic conditions and accelerate our journey towards more personalized healthcare solutions.
As this week’s exploration of the nexus between technology and longevity comes to a close, several insights demand contemplation. We’ve ventured into Brian Johnson’s algorithm-driven life choices, pushing boundaries in anti-aging pursuits. We’ve witnessed OM1’s strides in employing AI to unravel Parkinson’s mysteries and redefine personalized medicine. And with Arctop’s groundbreaking efforts, the translation of our cerebral symphony into virtual reality beckons unprecedented possibilities.
In this intricate ballet of life extension and technology, may our curiosity be unyielding and our innovations compassionate. Let us stride forward with audacity and hope, envisioning a horizon teeming with vitality and potential.
Until next time,
The Longr Reads Team
“We don’t stop playing because we grow old; we grow old because we stop playing.”
George Bernard Shaw, Playwright
Longr Reads’ of the Week
- Andrew Huberman Lab Podcast w/ Dr Peter Attia (Youtube)
- Some claim human lifespans can be lengthened indefinitely (The Economist)
- Longevity Clinics: What They Are, Services & More (Spannr)
